Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023
As approved by Novavax’ stockholders at a special meeting held on
As a result of the Reverse Stock Split and pursuant to Section 14.04(a) of the Indenture, effective
As a result of the foregoing adjustment to the conversion rate and pursuant to Section 14.03(d) of the Indenture, effective
Stock Price | |||||||||||||||||||||||||||||||||
Effective Date | $ | 111.20 | $ | 120.00 | $ | 130.00 | $ | 136.20 | $ | 140.00 | $ | 160.00 | $ | 200.00 | $ | 300.00 | $ | 400.00 | $ | 500.00 | $ | 600.00 | |||||||||||
January 29, 2016 | 1.6517 | 1.5755 | 1.3668 | 1.2563 | 1.1952 | 0.9315 | 0.5983 | 0.2342 | 0.0979 | 0.0373 | 0.0093 | ||||||||||||||||||||||
February 1, 2017 | 1.6517 | 1.6068 | 1.3859 | 1.2695 | 1.2053 | 0.9302 | 0.5881 | 0.2242 | 0.0918 | 0.0341 | 0.0079 | ||||||||||||||||||||||
February 1, 2018 | 1.6517 | 1.6198 | 1.3862 | 1.2639 | 1.1967 | 0.9113 | 0.5636 | 0.2069 | 0.0823 | 0.0292 | 0.0057 | ||||||||||||||||||||||
February 1, 2019 | 1.6517 | 1.6311 | 1.3803 | 1.2501 | 1.1789 | 0.8802 | 0.5267 | 0.1830 | 0.0697 | 0.0231 | 0.0032 | ||||||||||||||||||||||
February 1, 2020 | 1.6517 | 1.6055 | 1.3357 | 1.1972 | 1.1221 | 0.8124 | 0.4616 | 0.1478 | 0.0530 | 0.0156 | 0.0007 | ||||||||||||||||||||||
February 1, 2021 | 1.6517 | 1.5419 | 1.2458 | 1.0966 | 1.0167 | 0.6962 | 0.3602 | 0.1017 | 0.0341 | 0.0081 | 0.0000 | ||||||||||||||||||||||
February 1, 2022 | 1.6517 | 1.3911 | 1.0532 | 0.8889 | 0.8030 | 0.4796 | 0.1974 | 0.0475 | 0.0157 | 0.0019 | 0.0000 | ||||||||||||||||||||||
February 1, 2023 | 1.6517 | 0.9923 | 0.3512 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||||||||||||||||||
About
For more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.
Contacts:
Investors:
Senior Manager, Investor & Public Relations
[email protected]
240-268-2000
[email protected]
443-213-0506